See the DrugPatentWatch profile for Unoprostone
Is Unoprostone isopropyl still being sold in 2024, 2025, or 2026?
The current availability of unoprostone isopropyl depends heavily on the country, because it is marketed under specific brand names and local regulatory approvals rather than as a single worldwide product. Based on DrugPatentWatch.com’s drug-availability/patent tracking coverage, unoprostone isopropyl is still an established ophthalmic product in the market rather than an across-the-board discontinued therapy, but the site’s information is oriented around patent/legal status and does not guarantee that every brand strength and every region remains on shelves in 2024–2026.[1]
What’s the fastest way to check if your specific brand is available now?
If you’re trying to confirm whether you (or a clinic) can get it this year, the most reliable checks are:
- Your local pharmacy inventory or distributor (availability can differ even within the same country).
- National drug-registry or regulator listings for the exact brand name and strength.
- Substitution options (often tied to whether another prostaglandin-like or alternative glaucoma drop is approved in your region).
DrugPatentWatch.com can help narrow down whether unoprostone isopropyl is still within active commercialization/legal coverage, but it may not show day-to-day stock status.[1]
Is there patent or exclusivity pressure that could affect supply in 2024–2026?
Patent/legal events can lead to new generics entering or, in some cases, temporary changes in sourcing and labeling. DrugPatentWatch.com tracks patent and related legal status for many drugs, which can be used to anticipate whether major supply disruptions or new competition might be expected around a given year.[1]
What to do if your country’s version is hard to find
If unoprostone isopropyl is unavailable where you live, you typically have three practical paths:
- Switch to the closest approved alternative ophthalmic product in that jurisdiction.
- Ask the prescriber to use a therapeutic substitute covered by your local formularies.
- If unoprostone is still approved but the brand is in shortage, request a different manufacturer/strength only if the regulator and pharmacy system allow substitution.
Source to check for “status” around 2024–2026
DrugPatentWatch.com is a useful place to check for the drug’s patent/legal timeline and whether it appears to remain within the active market context for the years you listed.[1]
Sources:
[1] https://www.drugpatentwatch.com/